Capricor Therapeutics, Inc.
CAPR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $486 | $131 | $95 | $68 |
| - Cash | $11 | $15 | $10 | $35 |
| + Debt | $1 | $2 | $3 | $3 |
| Enterprise Value | $476 | $118 | $88 | $36 |
| Revenue | $22 | $25 | $3 | $0 |
| % Growth | -11.5% | 886.8% | 941.8% | – |
| Gross Profit | -$28 | -$11 | -$19 | $0 |
| % Margin | -124.4% | -44.8% | -755.1% | 100% |
| EBITDA | -$41 | -$23 | -$29 | -$21 |
| % Margin | -184.7% | -91.4% | -1,143% | -8,449.5% |
| Net Income | -$40 | -$22 | -$29 | -$20 |
| % Margin | -181.7% | -88.5% | -1,137.4% | -8,175.9% |
| EPS Diluted | -1.15 | -0.83 | -1.18 | -0.87 |
| % Growth | -38.6% | 29.7% | -35.6% | – |
| Operating Cash Flow | -$40 | -$26 | $5 | -$17 |
| Capital Expenditures | -$2 | -$2 | -$3 | -$1 |
| Free Cash Flow | -$42 | -$28 | $2 | -$18 |